Unknown

Dataset Information

0

Antimuscarinic Discontinuation in Patients with Overactive Bladder in Nursing Homes: A Retrospective Study of Medicare Beneficiaries.


ABSTRACT: INTRODUCTION:Although antimuscarinics form the first-line therapy in overactive bladder (OAB), little is known regarding antimuscarinic discontinuation among OAB patients in nursing homes. This study examined treatment patterns and predictors of antimuscarinic discontinuation among long-term nursing home (LTNH) residents with OAB. METHODS:The study cohort included LTNH residents (defined as residents staying???101 consecutive days) from the Minimum Data Set linked 2013-2015 Medicare claims data. Patients with OAB were defined by OAB-related claims and medication codes. Treatment patterns and discontinuation (medication gap???30 days) were characterized by examining OAB-specific antimuscarinics prescribed during LTNH stays. The Andersen Behavioral Model was used to identify predisposing, enabling and need factors that predict discontinuation. Kaplan-Meier curves and multivariable Cox proportional hazards regression model were used to assess the unadjusted and adjusted times to discontinuation, respectively, among different antimuscarinics. RESULTS:The mean age of the study cohort (n?=?11,012) was 81.6 years (±?8.5), 74.6% were female, and 89.8% were non-Hispanic White. The mean duration of nursing home stay was 530.1 (±?268.4) days. The most commonly prescribed OAB-specific antimuscarinic was oxybutynin (69.8%). Overall, 66.5% of the study cohort discontinued the index antimuscarinic. Multivariable Cox PH regression analysis revealed that compared to LTNH residents who initiated treatment with oxybutynin, treatment discontinuation was lower with solifenacin or fesoterodin and discontinuation was more frequent when treatment was initiated with tolterodine, darifenacin or trospium compared with oxybutynin. In addition, several need factors (comorbidities, medication use and anticholinergic burden, etc.) were associated with antimuscarinic discontinuation. CONCLUSION:About  two-thirds of LTNH residents with OAB discontinued their index antimuscarinic during their nursing home stay. There was significant variation in discontinuation based on the index antimuscarinic agent with lowest risk of discontiuation with solifenacin and fesoterodin. Concerted efforts to optimize antimuscarinic use are needed to improve the management of OAB in nursing homes.

SUBMITTER: Aparasu RR 

PROVIDER: S-EPMC7370971 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2011-01-01 | S-EPMC3044140 | BioStudies
2018-01-01 | S-EPMC5904003 | BioStudies
2018-01-01 | S-EPMC6160033 | BioStudies
2018-01-01 | S-EPMC5907635 | BioStudies
1000-01-01 | S-EPMC5689035 | BioStudies
2018-01-01 | S-EPMC6122705 | BioStudies
2019-01-01 | S-EPMC6795617 | BioStudies
2008-01-01 | S-EPMC2680263 | BioStudies
2018-01-01 | S-EPMC5766403 | BioStudies
2017-01-01 | S-EPMC5440896 | BioStudies